For years, the path has been established – study in the US, get a job there, and eventually vie for a green card. (AI image) US President Donald Trump has time and again said that he ‘loves’ Indian talent – but he doesn’t seem to want it in America – or so his policies suggest….
Regeneron Pharmaceuticals will make its newly approved gene therapy for a rare, genetic form of hearing loss available for free in the U.S. The company hasn’t yet decided how much it will charge in other countries, Regeneron CEO Leonard Schleifer told CNBC on Friday. “We haven’t set a price yet, but they should pay their…
Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on September 19, 2024 in London, England. Leon Neal | Getty Images News | Getty Images Once the go-to location for global drugmakers, Europe is now being squeezed by President Donald Trump’s aggressive trade and drug-pricing…
Read More “Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era” »
The New York Times told a federal judge Monday that the Pentagon has flouted the court’s ruling blocking it from enforcing its policy limiting journalists’ access to the Defense Department headquarters. The Times urged the court to compel the government to comply with the order to reinstate press credentials U.S. District Judge Paul Friedman did…
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images The future of the booming obesity drug market won’t hinge on drugs that deliver greater weight loss alone. Top executives from drugmakers big and small told CNBC that the next phase…
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Nov. 24, 2025. Tom Little | Reuters Novo Nordisk will start rolling out the first-ever GLP-1 pill for weight loss in the U.S. on Monday, the company announced, marking a new chapter of obesity…
Read More “First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. ” »
A planned Christmas Eve jazz concert at the Kennedy Center, a holiday tradition at the Washington, D.C., performing arts center dating back more than 20 years, has been canceled. The show’s host, musician Chuck Redd, told The Associated Press he called off the performance after the White House announced last week that President Trump’s name…
Read More “Kennedy Center Christmas Eve jazz concert canceled after Trump name added to building” »
President Donald Trump‘s move Thursday to sign an executive order easing federal restrictions on marijuana — and clearing the way for a Medicare pilot program covering CBD — caps a coordinated, yearlong push by the cannabis industry that combined traditional lobbying, sizable political donations, data-driven messaging and direct outreach to the president’s inner circle, industry…
Read More “Inside the dealmaking that pushed Trump to reclassify pot, expand access” »
Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it has cut the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic, adding to efforts by the company and the Trump administration to…
Read More “Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month” »
Oils containing CBD (Cannabidiol). Geoffroy Van Der Hasselt | AFP | Getty Images Cannabis stocks could be poised for a rally after years of stagnation, fueled by investor optimism over the possibility for new federal rules for hemp-derived products and signals that President Donald Trump could take a more permissive stance on marijuana. Publicly traded…
